
Phase II Study of Docetaxel and Celecoxib, a Cyclooxygenase-2 Inhibitor, in Elderly or Poor Performance Status (PS2) Patients with Advanced Non-small Cell Lung Cancer
Keywords: Elderly; PS2; COX-2; Docetaxel; Celecoxib; Non-small cell lung cancer